Pharma-Bio Serv (PBSV) EBT (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly EBT came in at $239353.0 in Q2 2026, up 137.3% on a YoY basis from $100864.0 in Q2 2025, and up 555.94% quarter-over-quarter from $36490.0 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) EBT (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported EBT for 17 consecutive years, with $239353.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT rose 137.3% year-over-year to $239353.0; the trailing twelve-month figure through Apr 2026 stood at $71068.0 (up 136.53% YoY), and the FY2025 full-year result was -$94260.0, up 87.52% from the prior year.
- EBT rose to $239353.0 in Q2 2026 per PBSV's latest filing, from $36490.0 in the prior quarter.
- Across five years, EBT topped out at $587451.0 in Q3 2023 and bottomed at -$290190.0 in Q3 2024.
- Historically, EBT has averaged $127888.1 across 5 years, with a median of $68677.0 in 2025.
- The sharpest annual moves came in 2024 and 2026: EBT plunged 149.4% in 2024, then jumped 278.1% in 2026.
- Over 5 years, EBT stood at $231044.0 in 2022, then slumped by 120.7% to -$47835.0 in 2023, then jumped by 68.96% to -$14849.0 in 2024, then soared by 128.65% to $4254.0 in 2025, then jumped by 5526.54% to $239353.0 in 2026.
- According to Business Quant data, EBT over the past three periods registered $239353.0, $36490.0, and $4254.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 3.15 Bn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 338.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 354.62 Mn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 150.77 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 251.00 Mn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 190.88 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 102.88 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 72.99 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 60.85 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 239,353.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 239,353.00 |
| Jan 31, 2026 | 36,490.00 |
| Oct 31, 2025 | 4,254.00 |
| Jul 31, 2025 | -209,029.00 |
| Apr 30, 2025 | 100,864.00 |
| Jan 31, 2025 | 9,651.00 |
| Oct 31, 2024 | -14,849.00 |
| Jul 31, 2024 | -290,190.00 |
| Apr 30, 2024 | -192,638.00 |
| Jan 31, 2024 | -257,771.00 |
| Oct 31, 2023 | -47,835.00 |
| Jul 31, 2023 | 587,451.00 |
| Apr 30, 2023 | 572,694.00 |
| Jan 31, 2023 | 575,177.00 |
| Oct 31, 2022 | 231,044.00 |
| Jul 31, 2022 | 315,822.00 |
| Apr 30, 2022 | 285,034.00 |
| Jan 31, 2022 | 356,463.00 |
| Oct 31, 2021 | -4.80 Mn |
| Jul 31, 2021 | 2.31 Mn |